Prevention of veno-occlusive disease/sinusoidal obstruction syndrome: a never-ending story and no easy answer-Reference-Cited by-同舟云学术

Prevention of veno-occlusive disease/sinusoidal obstruction syndrome: a never-ending story and no easy answer

Published:2023-05-25 Issue:8 Volume:58 Page:839-841
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Corbacioglu Selim^ORCID,Grupp Stephan A.^ORCID,Richardson Paul Gerard^ORCID,Duarte Rafael,Pagliuca Antonio,Ruutu Tapani,Mahadeo Kris,Carreras Enric^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02007-2.pdf

Reference13 articles.

1. Grupp SA, Corbacioglu S, Kang HJ, Teshima T, Khaw SL, Locatelli F, et al. Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial. Lancet Haematol. 2023. https://doi.org/10.1016/s2352-3026(23)00011-x.

2. Grupp S, Corbacioglu S, Jin Kang H, Teshima T, Zanette M, Lopez P, et al. A phase 3, randomized, adaptive study of defibrotide versus best supportive care (BSC) for the prevention of hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) in patients undergoing hematopoietic cell transplantation (HCT): preliminary results. In: ASH. Atlanta, USA, 2021.

3. Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012;379:1301–9. https://doi.org/10.1016/S0140-6736(11)61938-7.

4. Richardson P, Aggarwal S, Topaloglu O, Villa KF, Corbacioglu S. Systematic review of defibrotide studies in the treatment of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS). Bone Marrow Transplant. 2019;54:1951–62. https://doi.org/10.1038/s41409-019-0474-8.

5. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant. 2010;16:157–68. https://doi.org/10.1016/j.bbmt.2009.08.024.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANZTCT practice statement: sinusoidal obstruction syndrome/veno‐occlusive disease diagnosis and management;Internal Medicine Journal;2024-07-30

2. Diagnosing and Grading of Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplant of Children, Adolescent and Young Adults treated in a Pediatric Institution with Pediatric Protocols;Transplantation and Cellular Therapy;2024-07

3. A rare case of Gynura-segetum-related hepatic sinus obstruction syndrome complicated with alcoholic liver disease;Journal of the Pakistan Medical Association;2024-06-28

4. Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation -a multicentre study;The Lancet Regional Health - Americas;2024-05

5. Hepatic Complications;The EBMT Handbook;2024